On February 1, 2019, Mr. Zhijun Tong informed China Biologic Products Holdings, Inc. that he was resigning from his positions as the president and a director of the company due to personal reasons, effective immediately, and that his decision to resign did not result from any disagreement with the company on any matter relating to the company’s operations, policies or practices. On February 3, 2019, the board of directors of the company unanimously elected Mr. Joseph Chow to be the new chairman of the Board in succession to Mr. David Hui Li. Mr. Li continues to serve as a director on the Board.